nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—CNR1—muscle cancer	0.954	1	CbGaD
Nabilone—Dronabinol—CNR1—muscle cancer	0.00725	1	CrCbGaD
Nabilone—Pharyngitis—Dactinomycin—muscle cancer	0.000277	0.00714	CcSEcCtD
Nabilone—Depression—Vincristine—muscle cancer	0.000277	0.00714	CcSEcCtD
Nabilone—Scotoma—Doxorubicin—muscle cancer	0.000275	0.00708	CcSEcCtD
Nabilone—Stomatitis—Vincristine—muscle cancer	0.000271	0.00698	CcSEcCtD
Nabilone—Amblyopia—Doxorubicin—muscle cancer	0.00027	0.00696	CcSEcCtD
Nabilone—Flushing—Dactinomycin—muscle cancer	0.000259	0.00668	CcSEcCtD
Nabilone—Chills—Dactinomycin—muscle cancer	0.00025	0.00645	CcSEcCtD
Nabilone—Hallucination—Vincristine—muscle cancer	0.000248	0.0064	CcSEcCtD
Nabilone—Hypoaesthesia—Vincristine—muscle cancer	0.000248	0.0064	CcSEcCtD
Nabilone—Sweating increased—Etoposide—muscle cancer	0.000246	0.00634	CcSEcCtD
Nabilone—Depressed level of consciousness—Methotrexate—muscle cancer	0.000233	0.006	CcSEcCtD
Nabilone—Thinking abnormal—Doxorubicin—muscle cancer	0.000228	0.00587	CcSEcCtD
Nabilone—Ill-defined disorder—Dactinomycin—muscle cancer	0.000225	0.00581	CcSEcCtD
Nabilone—Anaemia—Dactinomycin—muscle cancer	0.000224	0.00579	CcSEcCtD
Nabilone—Coma—Methotrexate—muscle cancer	0.00022	0.00567	CcSEcCtD
Nabilone—Stomatitis—Etoposide—muscle cancer	0.000219	0.00565	CcSEcCtD
Nabilone—Malaise—Dactinomycin—muscle cancer	0.000219	0.00565	CcSEcCtD
Nabilone—Leukopenia—Dactinomycin—muscle cancer	0.000217	0.00561	CcSEcCtD
Nabilone—Coordination abnormal—Doxorubicin—muscle cancer	0.000212	0.00548	CcSEcCtD
Nabilone—Neck pain—Doxorubicin—muscle cancer	0.000211	0.00544	CcSEcCtD
Nabilone—Back pain—Vincristine—muscle cancer	0.00021	0.00541	CcSEcCtD
Nabilone—Myalgia—Dactinomycin—muscle cancer	0.000207	0.00533	CcSEcCtD
Nabilone—Abnormal dreams—Doxorubicin—muscle cancer	0.000206	0.00531	CcSEcCtD
Nabilone—Discomfort—Dactinomycin—muscle cancer	0.000204	0.00527	CcSEcCtD
Nabilone—Hypoaesthesia—Etoposide—muscle cancer	0.000201	0.00518	CcSEcCtD
Nabilone—Anaemia—Vincristine—muscle cancer	0.000201	0.00517	CcSEcCtD
Nabilone—Agitation—Vincristine—muscle cancer	0.000199	0.00514	CcSEcCtD
Nabilone—Photosensitivity—Methotrexate—muscle cancer	0.000199	0.00513	CcSEcCtD
Nabilone—Infection—Dactinomycin—muscle cancer	0.000197	0.00508	CcSEcCtD
Nabilone—Vertigo—Vincristine—muscle cancer	0.000195	0.00503	CcSEcCtD
Nabilone—Leukopenia—Vincristine—muscle cancer	0.000194	0.00501	CcSEcCtD
Nabilone—Dry eye—Doxorubicin—muscle cancer	0.000193	0.00497	CcSEcCtD
Nabilone—Coma—Doxorubicin—muscle cancer	0.000191	0.00491	CcSEcCtD
Nabilone—Anorexia—Dactinomycin—muscle cancer	0.000189	0.00487	CcSEcCtD
Nabilone—Eye disorder—Etoposide—muscle cancer	0.000189	0.00487	CcSEcCtD
Nabilone—Convulsion—Vincristine—muscle cancer	0.000188	0.00485	CcSEcCtD
Nabilone—Flushing—Etoposide—muscle cancer	0.000187	0.00483	CcSEcCtD
Nabilone—Hypertension—Vincristine—muscle cancer	0.000187	0.00483	CcSEcCtD
Nabilone—Myalgia—Vincristine—muscle cancer	0.000185	0.00476	CcSEcCtD
Nabilone—Visual disturbance—Methotrexate—muscle cancer	0.000185	0.00476	CcSEcCtD
Nabilone—Chills—Etoposide—muscle cancer	0.000181	0.00467	CcSEcCtD
Nabilone—Mental disability—Doxorubicin—muscle cancer	0.000181	0.00467	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000181	0.00466	CcSEcCtD
Nabilone—Cerebrovascular accident—Methotrexate—muscle cancer	0.000178	0.0046	CcSEcCtD
Nabilone—Infection—Vincristine—muscle cancer	0.000176	0.00454	CcSEcCtD
Nabilone—Photosensitivity—Doxorubicin—muscle cancer	0.000172	0.00445	CcSEcCtD
Nabilone—Decreased appetite—Dactinomycin—muscle cancer	0.000172	0.00444	CcSEcCtD
Nabilone—Hyperhidrosis—Vincristine—muscle cancer	0.000171	0.00441	CcSEcCtD
Nabilone—Fatigue—Dactinomycin—muscle cancer	0.000171	0.00441	CcSEcCtD
Nabilone—Back pain—Etoposide—muscle cancer	0.00017	0.00438	CcSEcCtD
Nabilone—Pain—Dactinomycin—muscle cancer	0.00017	0.00437	CcSEcCtD
Nabilone—Anorexia—Vincristine—muscle cancer	0.000169	0.00435	CcSEcCtD
Nabilone—Irritability—Methotrexate—muscle cancer	0.000167	0.0043	CcSEcCtD
Nabilone—Mood swings—Methotrexate—muscle cancer	0.000166	0.00427	CcSEcCtD
Nabilone—Hypotension—Vincristine—muscle cancer	0.000165	0.00427	CcSEcCtD
Nabilone—Ataxia—Methotrexate—muscle cancer	0.000164	0.00424	CcSEcCtD
Nabilone—Feeling abnormal—Dactinomycin—muscle cancer	0.000163	0.00421	CcSEcCtD
Nabilone—Ill-defined disorder—Etoposide—muscle cancer	0.000163	0.00421	CcSEcCtD
Nabilone—Anaemia—Etoposide—muscle cancer	0.000162	0.00419	CcSEcCtD
Nabilone—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000162	0.00418	CcSEcCtD
Nabilone—Hot flush—Doxorubicin—muscle cancer	0.000162	0.00417	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000161	0.00416	CcSEcCtD
Nabilone—Increased appetite—Doxorubicin—muscle cancer	0.000161	0.00415	CcSEcCtD
Nabilone—Menopausal symptoms—Doxorubicin—muscle cancer	0.00016	0.00414	CcSEcCtD
Nabilone—Insomnia—Vincristine—muscle cancer	0.00016	0.00413	CcSEcCtD
Nabilone—Paraesthesia—Vincristine—muscle cancer	0.000159	0.0041	CcSEcCtD
Nabilone—Malaise—Etoposide—muscle cancer	0.000159	0.00409	CcSEcCtD
Nabilone—Vertigo—Etoposide—muscle cancer	0.000158	0.00407	CcSEcCtD
Nabilone—Leukopenia—Etoposide—muscle cancer	0.000157	0.00406	CcSEcCtD
Nabilone—Abdominal pain—Dactinomycin—muscle cancer	0.000157	0.00404	CcSEcCtD
Nabilone—Body temperature increased—Dactinomycin—muscle cancer	0.000157	0.00404	CcSEcCtD
Nabilone—Loss of consciousness—Etoposide—muscle cancer	0.000155	0.00398	CcSEcCtD
Nabilone—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000155	0.00398	CcSEcCtD
Nabilone—Decreased appetite—Vincristine—muscle cancer	0.000154	0.00397	CcSEcCtD
Nabilone—Cough—Etoposide—muscle cancer	0.000153	0.00396	CcSEcCtD
Nabilone—Fatigue—Vincristine—muscle cancer	0.000153	0.00394	CcSEcCtD
Nabilone—Convulsion—Etoposide—muscle cancer	0.000152	0.00393	CcSEcCtD
Nabilone—Hypertension—Etoposide—muscle cancer	0.000152	0.00391	CcSEcCtD
Nabilone—Pain—Vincristine—muscle cancer	0.000151	0.0039	CcSEcCtD
Nabilone—Constipation—Vincristine—muscle cancer	0.000151	0.0039	CcSEcCtD
Nabilone—Chest pain—Etoposide—muscle cancer	0.00015	0.00386	CcSEcCtD
Nabilone—Affect lability—Doxorubicin—muscle cancer	0.000149	0.00384	CcSEcCtD
Nabilone—Discomfort—Etoposide—muscle cancer	0.000148	0.00381	CcSEcCtD
Nabilone—Face oedema—Doxorubicin—muscle cancer	0.000146	0.00377	CcSEcCtD
Nabilone—Hypersensitivity—Dactinomycin—muscle cancer	0.000146	0.00377	CcSEcCtD
Nabilone—Gastrointestinal pain—Vincristine—muscle cancer	0.000145	0.00373	CcSEcCtD
Nabilone—Confusional state—Etoposide—muscle cancer	0.000145	0.00373	CcSEcCtD
Nabilone—Mood swings—Doxorubicin—muscle cancer	0.000143	0.0037	CcSEcCtD
Nabilone—Infection—Etoposide—muscle cancer	0.000143	0.00367	CcSEcCtD
Nabilone—Ataxia—Doxorubicin—muscle cancer	0.000142	0.00367	CcSEcCtD
Nabilone—Asthenia—Dactinomycin—muscle cancer	0.000142	0.00367	CcSEcCtD
Nabilone—Tachycardia—Etoposide—muscle cancer	0.00014	0.00361	CcSEcCtD
Nabilone—Abdominal pain—Vincristine—muscle cancer	0.00014	0.00361	CcSEcCtD
Nabilone—Body temperature increased—Vincristine—muscle cancer	0.00014	0.00361	CcSEcCtD
Nabilone—Hyperhidrosis—Etoposide—muscle cancer	0.000139	0.00358	CcSEcCtD
Nabilone—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000138	0.00357	CcSEcCtD
Nabilone—Photosensitivity reaction—Methotrexate—muscle cancer	0.000138	0.00356	CcSEcCtD
Nabilone—Anorexia—Etoposide—muscle cancer	0.000137	0.00353	CcSEcCtD
Nabilone—Diarrhoea—Dactinomycin—muscle cancer	0.000136	0.0035	CcSEcCtD
Nabilone—Drowsiness—Methotrexate—muscle cancer	0.000135	0.00347	CcSEcCtD
Nabilone—Depression—Methotrexate—muscle cancer	0.000134	0.00346	CcSEcCtD
Nabilone—Hypotension—Etoposide—muscle cancer	0.000134	0.00346	CcSEcCtD
Nabilone—Gastritis—Doxorubicin—muscle cancer	0.000134	0.00345	CcSEcCtD
Nabilone—Stomatitis—Methotrexate—muscle cancer	0.000131	0.00339	CcSEcCtD
Nabilone—Hypersensitivity—Vincristine—muscle cancer	0.00013	0.00336	CcSEcCtD
Nabilone—Paraesthesia—Etoposide—muscle cancer	0.000129	0.00332	CcSEcCtD
Nabilone—Dyspnoea—Etoposide—muscle cancer	0.000128	0.0033	CcSEcCtD
Nabilone—Somnolence—Etoposide—muscle cancer	0.000128	0.00329	CcSEcCtD
Nabilone—Epistaxis—Methotrexate—muscle cancer	0.000127	0.00328	CcSEcCtD
Nabilone—Asthenia—Vincristine—muscle cancer	0.000127	0.00328	CcSEcCtD
Nabilone—Vomiting—Dactinomycin—muscle cancer	0.000126	0.00325	CcSEcCtD
Nabilone—Rash—Dactinomycin—muscle cancer	0.000125	0.00322	CcSEcCtD
Nabilone—Decreased appetite—Etoposide—muscle cancer	0.000125	0.00322	CcSEcCtD
Nabilone—Fatigue—Etoposide—muscle cancer	0.000124	0.00319	CcSEcCtD
Nabilone—Constipation—Etoposide—muscle cancer	0.000123	0.00316	CcSEcCtD
Nabilone—Pain—Etoposide—muscle cancer	0.000123	0.00316	CcSEcCtD
Nabilone—Diarrhoea—Vincristine—muscle cancer	0.000121	0.00312	CcSEcCtD
Nabilone—Pollakiuria—Doxorubicin—muscle cancer	0.000121	0.00312	CcSEcCtD
Nabilone—Pharyngitis—Methotrexate—muscle cancer	0.00012	0.0031	CcSEcCtD
Nabilone—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000119	0.00308	CcSEcCtD
Nabilone—Feeling abnormal—Etoposide—muscle cancer	0.000118	0.00305	CcSEcCtD
Nabilone—Nausea—Dactinomycin—muscle cancer	0.000118	0.00304	CcSEcCtD
Nabilone—Gastrointestinal pain—Etoposide—muscle cancer	0.000117	0.00302	CcSEcCtD
Nabilone—Dizziness—Vincristine—muscle cancer	0.000117	0.00302	CcSEcCtD
Nabilone—Drowsiness—Doxorubicin—muscle cancer	0.000117	0.00301	CcSEcCtD
Nabilone—Visual impairment—Methotrexate—muscle cancer	0.000117	0.00301	CcSEcCtD
Nabilone—Stomatitis—Doxorubicin—muscle cancer	0.000114	0.00293	CcSEcCtD
Nabilone—Abdominal pain—Etoposide—muscle cancer	0.000113	0.00292	CcSEcCtD
Nabilone—Body temperature increased—Etoposide—muscle cancer	0.000113	0.00292	CcSEcCtD
Nabilone—Eye disorder—Methotrexate—muscle cancer	0.000113	0.00291	CcSEcCtD
Nabilone—Tinnitus—Methotrexate—muscle cancer	0.000113	0.00291	CcSEcCtD
Nabilone—Vomiting—Vincristine—muscle cancer	0.000113	0.0029	CcSEcCtD
Nabilone—Rash—Vincristine—muscle cancer	0.000112	0.00288	CcSEcCtD
Nabilone—Dermatitis—Vincristine—muscle cancer	0.000112	0.00288	CcSEcCtD
Nabilone—Headache—Vincristine—muscle cancer	0.000111	0.00286	CcSEcCtD
Nabilone—Epistaxis—Doxorubicin—muscle cancer	0.00011	0.00284	CcSEcCtD
Nabilone—Chills—Methotrexate—muscle cancer	0.000109	0.0028	CcSEcCtD
Nabilone—Hypersensitivity—Etoposide—muscle cancer	0.000106	0.00273	CcSEcCtD
Nabilone—Nausea—Vincristine—muscle cancer	0.000105	0.00271	CcSEcCtD
Nabilone—Hypoaesthesia—Doxorubicin—muscle cancer	0.000104	0.00269	CcSEcCtD
Nabilone—Pharyngitis—Doxorubicin—muscle cancer	0.000104	0.00268	CcSEcCtD
Nabilone—Asthenia—Etoposide—muscle cancer	0.000103	0.00265	CcSEcCtD
Nabilone—Back pain—Methotrexate—muscle cancer	0.000102	0.00263	CcSEcCtD
Nabilone—Pruritus—Etoposide—muscle cancer	0.000102	0.00262	CcSEcCtD
Nabilone—Visual impairment—Doxorubicin—muscle cancer	0.000101	0.0026	CcSEcCtD
Nabilone—Vision blurred—Methotrexate—muscle cancer	9.92e-05	0.00256	CcSEcCtD
Nabilone—Diarrhoea—Etoposide—muscle cancer	9.82e-05	0.00253	CcSEcCtD
Nabilone—Eye disorder—Doxorubicin—muscle cancer	9.79e-05	0.00252	CcSEcCtD
Nabilone—Ill-defined disorder—Methotrexate—muscle cancer	9.77e-05	0.00252	CcSEcCtD
Nabilone—Tinnitus—Doxorubicin—muscle cancer	9.77e-05	0.00252	CcSEcCtD
Nabilone—Anaemia—Methotrexate—muscle cancer	9.73e-05	0.00251	CcSEcCtD
Nabilone—Flushing—Doxorubicin—muscle cancer	9.72e-05	0.00251	CcSEcCtD
Nabilone—Malaise—Methotrexate—muscle cancer	9.5e-05	0.00245	CcSEcCtD
Nabilone—Dizziness—Etoposide—muscle cancer	9.49e-05	0.00245	CcSEcCtD
Nabilone—Vertigo—Methotrexate—muscle cancer	9.46e-05	0.00244	CcSEcCtD
Nabilone—Leukopenia—Methotrexate—muscle cancer	9.43e-05	0.00243	CcSEcCtD
Nabilone—Chills—Doxorubicin—muscle cancer	9.4e-05	0.00242	CcSEcCtD
Nabilone—Arrhythmia—Doxorubicin—muscle cancer	9.36e-05	0.00241	CcSEcCtD
Nabilone—Cough—Methotrexate—muscle cancer	9.19e-05	0.00237	CcSEcCtD
Nabilone—Convulsion—Methotrexate—muscle cancer	9.12e-05	0.00235	CcSEcCtD
Nabilone—Vomiting—Etoposide—muscle cancer	9.12e-05	0.00235	CcSEcCtD
Nabilone—Rash—Etoposide—muscle cancer	9.05e-05	0.00233	CcSEcCtD
Nabilone—Dermatitis—Etoposide—muscle cancer	9.04e-05	0.00233	CcSEcCtD
Nabilone—Headache—Etoposide—muscle cancer	8.99e-05	0.00232	CcSEcCtD
Nabilone—Myalgia—Methotrexate—muscle cancer	8.96e-05	0.00231	CcSEcCtD
Nabilone—Chest pain—Methotrexate—muscle cancer	8.96e-05	0.00231	CcSEcCtD
Nabilone—Arthralgia—Methotrexate—muscle cancer	8.96e-05	0.00231	CcSEcCtD
Nabilone—Tension—Doxorubicin—muscle cancer	8.95e-05	0.00231	CcSEcCtD
Nabilone—Discomfort—Methotrexate—muscle cancer	8.86e-05	0.00228	CcSEcCtD
Nabilone—Nervousness—Doxorubicin—muscle cancer	8.86e-05	0.00228	CcSEcCtD
Nabilone—Back pain—Doxorubicin—muscle cancer	8.82e-05	0.00227	CcSEcCtD
Nabilone—Confusional state—Methotrexate—muscle cancer	8.67e-05	0.00223	CcSEcCtD
Nabilone—Vision blurred—Doxorubicin—muscle cancer	8.59e-05	0.00222	CcSEcCtD
Nabilone—Infection—Methotrexate—muscle cancer	8.54e-05	0.0022	CcSEcCtD
Nabilone—Nausea—Etoposide—muscle cancer	8.52e-05	0.0022	CcSEcCtD
Nabilone—Ill-defined disorder—Doxorubicin—muscle cancer	8.46e-05	0.00218	CcSEcCtD
Nabilone—Anaemia—Doxorubicin—muscle cancer	8.43e-05	0.00217	CcSEcCtD
Nabilone—Agitation—Doxorubicin—muscle cancer	8.38e-05	0.00216	CcSEcCtD
Nabilone—Hyperhidrosis—Methotrexate—muscle cancer	8.31e-05	0.00214	CcSEcCtD
Nabilone—Malaise—Doxorubicin—muscle cancer	8.22e-05	0.00212	CcSEcCtD
Nabilone—Vertigo—Doxorubicin—muscle cancer	8.19e-05	0.00211	CcSEcCtD
Nabilone—Anorexia—Methotrexate—muscle cancer	8.19e-05	0.00211	CcSEcCtD
Nabilone—Syncope—Doxorubicin—muscle cancer	8.18e-05	0.00211	CcSEcCtD
Nabilone—Leukopenia—Doxorubicin—muscle cancer	8.16e-05	0.0021	CcSEcCtD
Nabilone—Palpitations—Doxorubicin—muscle cancer	8.06e-05	0.00208	CcSEcCtD
Nabilone—Hypotension—Methotrexate—muscle cancer	8.03e-05	0.00207	CcSEcCtD
Nabilone—Loss of consciousness—Doxorubicin—muscle cancer	8.01e-05	0.00207	CcSEcCtD
Nabilone—Cough—Doxorubicin—muscle cancer	7.96e-05	0.00205	CcSEcCtD
Nabilone—Convulsion—Doxorubicin—muscle cancer	7.9e-05	0.00204	CcSEcCtD
Nabilone—Hypertension—Doxorubicin—muscle cancer	7.87e-05	0.00203	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Methotrexate—muscle cancer	7.83e-05	0.00202	CcSEcCtD
Nabilone—Insomnia—Methotrexate—muscle cancer	7.77e-05	0.002	CcSEcCtD
Nabilone—Arthralgia—Doxorubicin—muscle cancer	7.76e-05	0.002	CcSEcCtD
Nabilone—Chest pain—Doxorubicin—muscle cancer	7.76e-05	0.002	CcSEcCtD
Nabilone—Myalgia—Doxorubicin—muscle cancer	7.76e-05	0.002	CcSEcCtD
Nabilone—Anxiety—Doxorubicin—muscle cancer	7.74e-05	0.00199	CcSEcCtD
Nabilone—Paraesthesia—Methotrexate—muscle cancer	7.72e-05	0.00199	CcSEcCtD
Nabilone—Discomfort—Doxorubicin—muscle cancer	7.67e-05	0.00198	CcSEcCtD
Nabilone—Dyspnoea—Methotrexate—muscle cancer	7.66e-05	0.00198	CcSEcCtD
Nabilone—Somnolence—Methotrexate—muscle cancer	7.64e-05	0.00197	CcSEcCtD
Nabilone—Dry mouth—Doxorubicin—muscle cancer	7.59e-05	0.00196	CcSEcCtD
Nabilone—Dyspepsia—Methotrexate—muscle cancer	7.56e-05	0.00195	CcSEcCtD
Nabilone—Confusional state—Doxorubicin—muscle cancer	7.5e-05	0.00193	CcSEcCtD
Nabilone—Decreased appetite—Methotrexate—muscle cancer	7.47e-05	0.00193	CcSEcCtD
Nabilone—Fatigue—Methotrexate—muscle cancer	7.41e-05	0.00191	CcSEcCtD
Nabilone—Infection—Doxorubicin—muscle cancer	7.39e-05	0.00191	CcSEcCtD
Nabilone—Pain—Methotrexate—muscle cancer	7.35e-05	0.00189	CcSEcCtD
Nabilone—Shock—Doxorubicin—muscle cancer	7.32e-05	0.00189	CcSEcCtD
Nabilone—Tachycardia—Doxorubicin—muscle cancer	7.26e-05	0.00187	CcSEcCtD
Nabilone—Hyperhidrosis—Doxorubicin—muscle cancer	7.19e-05	0.00185	CcSEcCtD
Nabilone—Anorexia—Doxorubicin—muscle cancer	7.09e-05	0.00183	CcSEcCtD
Nabilone—Feeling abnormal—Methotrexate—muscle cancer	7.08e-05	0.00183	CcSEcCtD
Nabilone—Gastrointestinal pain—Methotrexate—muscle cancer	7.03e-05	0.00181	CcSEcCtD
Nabilone—Hypotension—Doxorubicin—muscle cancer	6.95e-05	0.00179	CcSEcCtD
Nabilone—Body temperature increased—Methotrexate—muscle cancer	6.79e-05	0.00175	CcSEcCtD
Nabilone—Abdominal pain—Methotrexate—muscle cancer	6.79e-05	0.00175	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Doxorubicin—muscle cancer	6.78e-05	0.00175	CcSEcCtD
Nabilone—Insomnia—Doxorubicin—muscle cancer	6.73e-05	0.00174	CcSEcCtD
Nabilone—Paraesthesia—Doxorubicin—muscle cancer	6.68e-05	0.00172	CcSEcCtD
Nabilone—Dyspnoea—Doxorubicin—muscle cancer	6.63e-05	0.00171	CcSEcCtD
Nabilone—Somnolence—Doxorubicin—muscle cancer	6.62e-05	0.00171	CcSEcCtD
Nabilone—Dyspepsia—Doxorubicin—muscle cancer	6.55e-05	0.00169	CcSEcCtD
Nabilone—Decreased appetite—Doxorubicin—muscle cancer	6.47e-05	0.00167	CcSEcCtD
Nabilone—Fatigue—Doxorubicin—muscle cancer	6.42e-05	0.00165	CcSEcCtD
Nabilone—Pain—Doxorubicin—muscle cancer	6.36e-05	0.00164	CcSEcCtD
Nabilone—Constipation—Doxorubicin—muscle cancer	6.36e-05	0.00164	CcSEcCtD
Nabilone—Hypersensitivity—Methotrexate—muscle cancer	6.33e-05	0.00163	CcSEcCtD
Nabilone—Asthenia—Methotrexate—muscle cancer	6.17e-05	0.00159	CcSEcCtD
Nabilone—Feeling abnormal—Doxorubicin—muscle cancer	6.13e-05	0.00158	CcSEcCtD
Nabilone—Gastrointestinal pain—Doxorubicin—muscle cancer	6.08e-05	0.00157	CcSEcCtD
Nabilone—Pruritus—Methotrexate—muscle cancer	6.08e-05	0.00157	CcSEcCtD
Nabilone—Abdominal pain—Doxorubicin—muscle cancer	5.88e-05	0.00152	CcSEcCtD
Nabilone—Body temperature increased—Doxorubicin—muscle cancer	5.88e-05	0.00152	CcSEcCtD
Nabilone—Diarrhoea—Methotrexate—muscle cancer	5.88e-05	0.00152	CcSEcCtD
Nabilone—Dizziness—Methotrexate—muscle cancer	5.68e-05	0.00147	CcSEcCtD
Nabilone—Hypersensitivity—Doxorubicin—muscle cancer	5.48e-05	0.00141	CcSEcCtD
Nabilone—Vomiting—Methotrexate—muscle cancer	5.46e-05	0.00141	CcSEcCtD
Nabilone—Rash—Methotrexate—muscle cancer	5.42e-05	0.0014	CcSEcCtD
Nabilone—Dermatitis—Methotrexate—muscle cancer	5.41e-05	0.0014	CcSEcCtD
Nabilone—Headache—Methotrexate—muscle cancer	5.38e-05	0.00139	CcSEcCtD
Nabilone—Asthenia—Doxorubicin—muscle cancer	5.34e-05	0.00138	CcSEcCtD
Nabilone—Pruritus—Doxorubicin—muscle cancer	5.26e-05	0.00136	CcSEcCtD
Nabilone—Nausea—Methotrexate—muscle cancer	5.1e-05	0.00132	CcSEcCtD
Nabilone—Diarrhoea—Doxorubicin—muscle cancer	5.09e-05	0.00131	CcSEcCtD
Nabilone—Dizziness—Doxorubicin—muscle cancer	4.92e-05	0.00127	CcSEcCtD
Nabilone—Vomiting—Doxorubicin—muscle cancer	4.73e-05	0.00122	CcSEcCtD
Nabilone—Rash—Doxorubicin—muscle cancer	4.69e-05	0.00121	CcSEcCtD
Nabilone—Dermatitis—Doxorubicin—muscle cancer	4.69e-05	0.00121	CcSEcCtD
Nabilone—Headache—Doxorubicin—muscle cancer	4.66e-05	0.0012	CcSEcCtD
Nabilone—Nausea—Doxorubicin—muscle cancer	4.42e-05	0.00114	CcSEcCtD
